International Clinical Trial: Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07458269) titled 'Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes' on March 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Kailera

Condition: Obesity

Intervention: Drug: KAI-9531

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: March 2026

Target Sample Size: 250

To know more, visit https://clinicaltrials.gov/study/NCT07458269

Published by HT Digital Content Services with pe...